Pharmathen S.A.
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
0
Ending by 2030
Oct 2031
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Dec 25, 2026The maintenance fee for Pharmaceutical composition comprising a triazole antifungal agent and method for preparation thereof (US 10,328,076) comes due Dec 25, 2026. Unpaid by Jun 25, 2027, it lapses early.
- 1 fee due Oct 30, 2027The maintenance fee for Pediatric Powder for Oral Suspension Containing Antiviral Agent and Method for the Preparation Thereof (US 11,969,429) comes due Oct 30, 2027. Unpaid by May 1, 2028, it lapses early.
Recent changes
- 1 of the patents on this record was granted since Aug 17, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,675,551 | Sublingual pharmaceutical composition containing an antihistamine agent and method for the preparation thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 9,849,147 | Pharmaceutical composition containing phosphate binding polymer In force · From the USPTO record | In force | From the USPTO record | |
| US 9,561,186 | Method for improving the bioavailability of low aqueous solubility drugs In force (reinstated) · From the USPTO record | In force (reinstated) | From the USPTO record | |
| US 9,943,483 | Preparation of peptide loaded PLGA microspheres with controlled release characteristics In force · From the USPTO record | In force | From the USPTO record | |
| US 9,943,484 | Preparation of polylactide-polyglycolide microparticles having a sigmoidal release profile In force · From the USPTO record | In force | From the USPTO record | |
| US 10,328,076 | Pharmaceutical composition comprising a triazole antifungal agent and method for preparation thereof In force · From the USPTO record | In force | From the USPTO record | |
| US 12,453,732 | Pediatric Powder for Oral Suspension Containing Antiviral Agent and Method for the Preparation Thereof In force · Low confidence | In force | Low confidence | |
| US 12,458,645 | Pediatric Powder for Oral Suspension Containing Antiviral Agent and Method for the Preparation Thereof In force · Low confidence | In force | Low confidence | |
| US 11,969,429 | Pediatric Powder for Oral Suspension Containing Antiviral Agent and Method for the Preparation Thereof In force · Medium confidence | In force | Medium confidence | |
| US 11,318,114 | Water dispersible mini-tablets comprising Enalapril for treatment of hypertension in a pediatric population and method of preparation thereof In force · From the USPTO record | In force | From the USPTO record |
Also on record, not counted in the 14: 4 patents in force now held by others · 5 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 pending · 2 abandoned · 32 no status recorded